Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis

Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis

(2011) Roland Walter et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors

(2011) Nathalie C. Leite et al.   LIVER INTERNATIONAL

Significance of serum adiponectin levels in patients with chronic liver disease

(2010) Maria Luisa Balmer et al.   CLINICAL SCIENCE

Elevated TGF-β1 levels might protect HCV/ HIV-coinfected patients from liver fibrosis

(2010) Norma I. Rallón et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Generalizability of the Nonalcoholic Steatohepatitis Clinical Research Network Histologic Scoring System for Nonalcoholic Fatty Liver Disease

(2010) Ravi Juluri et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus

(2010) Nathalie C. Leite et al.   LIVER INTERNATIONAL

Low Serum Adiponectin Levels Are Predictive of Advanced Hepatic Fibrosis in Patients With NAFLD

(2009) Savvoula Savvidou et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Cytokines in the Pathogenesis of Fatty Liver and Disease Progression to Steatohepatitis: Implications for Treatment

(2008) Christine Carter-Kent et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis

(2008) Anna Wieckowska et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effects of Liver Biopsy Sample Length and Number of Readings on Sampling Variability in Nonalcoholic Fatty Liver Disease

(2008) Raj Vuppalanchi et al.   Clinical Gastroenterology and Hepatology

A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)

(2008) Zobair M. Younossi et al.   OBESITY SURGERY